日本伯格氏病患者的现状。
Current status of patients with buerger disease in Japan.
作者信息
Hida Noriyuki, Ohta Takashi
机构信息
Department of Vascular Surgery, Aichi Medical University, Nagakute, Aichi, Japan.
出版信息
Ann Vasc Dis. 2013;6(3):617-23. doi: 10.3400/avd.oa.13-00012. Epub 2013 Aug 12.
Abstract
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF JAPANESE PATIENTS WITH BUERGER DISEASE (THROMBOANGIITIS OBLITERANS: TAO) were analyzed based on the Ministry of Health, Labour and Welfare (MHLW) database in 2009. A total of 129 new patients and 3639 patients in follow-up were selected according to the clinical criteria of TAO. The current number of patients with TAO in Japan is estimated at about 4000. The clinical course is relatively favorable, and the rates of limb morbidity and mortality were not completely discouraging.
摘要
基于2009年厚生劳动省（MHLW）数据库，对日本血栓闭塞性脉管炎（TAO）患者的患病率和临床特征进行了分析。根据TAO的临床标准，共选取了129例新患者和3639例随访患者。据估计，日本目前TAO患者数量约为4000人。临床病程相对良好，肢体发病和死亡率并非完全令人沮丧。
相似文献
1
Current status of patients with buerger disease in Japan.
Ann Vasc Dis. 2013;6(3):617-23. doi: 10.3400/avd.oa.13-00012. Epub 2013 Aug 12.
2
Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible.
AJR Am J Roentgenol. 2021 Feb;216(2):421-427. doi: 10.2214/AJR.20.23023. Epub 2020 Dec 16.
3
Buerger disease (thromboangiitis obliterans).
Tech Vasc Interv Radiol. 2014 Dec;17(4):234-40. doi: 10.1053/j.tvir.2014.11.003. Epub 2014 Nov 13.
4
Thromboangiitis obliterans: classic and new morphological features.
Virchows Arch. 2000 Jan;436(1):59-67. doi: 10.1007/pl00008199.
5
Reappraisal of thromboangiitis obliterans--a pathological contribution.
Verh Dtsch Ges Pathol. 2004;88:231-6.
6
[Thromboangiitis obliterans (Buerger disease) discovered by symptoms of arthralgia in a young woman].
Praxis (Bern 1994). 1997 Dec 3;86(49):1945-8.
7
D-dimer levels in patients with thromboangiitis obliterans.
Natl Med J India. 2019 May-Jun;32(3):134-136. doi: 10.4103/0970-258X.278685.
8
Thromboangiitis obliterans (Buerger's disease).
Vasa. 2014 Sep;43(5):337-46. doi: 10.1024/0301-1526/a000371.
9
Effectiveness of bosentan in the treatment of ischemic lesions in a case of thromboangiitis obliterans (Buerger disease): a case report.
Dermatol Online J. 2011 Jul 15;17(7):4.
10
Antiphospholipid antibodies in thromboangiitis obliterans.
Vasc Med. 2002;7(4):259-64. doi: 10.1191/1358863x02vm452oa.
引用本文的文献
1
Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans - Study Protocol for a Multicenter Prospective Interventional Trial.
Circ Rep. 2020 Sep 15;2(10):630-634. doi: 10.1253/circrep.CR-20-0086.
2
Three cases of dorsal metatarsal artery bypass in patients with Buerger disease.
J Vasc Surg Cases Innov Tech. 2018 Aug 17;4(3):185-188. doi: 10.1016/j.jvscit.2018.03.011. eCollection 2018 Sep.
3
Buerger's disease: providing integrated care.
J Multidiscip Healthc. 2016 Oct 12;9:511-518. doi: 10.2147/JMDH.S109985. eCollection 2016.
4
The Incidence and Prevalence of Thromboangiitis Obliterans in Taiwan: A Nationwide, Population-based Analysis of Data Collected from 2002 to 2011.
Clinics (Sao Paulo). 2016 Jul;71(7):399-403. doi: 10.6061/clinics/2016(07)08.
本文引用的文献
1
Buerger disease, smoking, and periodontitis.
Ann Vasc Dis. 2008;1(2):80-4. doi: 10.3400/avd.AVDct00108. Epub 2008 Oct 24.
2
Buerger's disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran.
Arch Med Sci. 2010 Jun 30;6(3):343-7. doi: 10.5114/aoms.2010.14253.
3
Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society.
Circ J. 2011;75(2):474-503. doi: 10.1253/circj.cj-88-0007. Epub 2011 Jan 20.
4
Current pathological and clinical aspects of Buerger's disease in Japan.
Ann Vasc Surg. 2006 Jan;20(1):148-56. doi: 10.1007/s10016-005-9436-2.
5
Oral bacteria in the occluded arteries of patients with Buerger disease.
J Vasc Surg. 2005 Jul;42(1):107-15. doi: 10.1016/j.jvs.2005.03.016.
6
Clinical and social consequences of Buerger disease.
J Vasc Surg. 2004 Jan;39(1):176-80. doi: 10.1016/j.jvs.2003.08.006.
7
Current status of thromboangiitis obliterans (Buerger's disease) in Japan.
Int J Cardiol. 2000 Aug 31;75 Suppl 1:S175-81. doi: 10.1016/s0167-5273(00)00190-x.
8
Factors affecting the long-term outcome of Buerger's disease (thromboangiitis obliterans).
Int Angiol. 1999 Mar;18(1):58-64.
9
Decrease in prevalence of Buerger's disease in Japan.
Surgery. 1998 Sep;124(3):498-502.
10
Buerger's disease: diagnosis and management.
Cardiovasc Surg. 1993 Jun;1(3):207-14.
Zotero 插件